Skip to main content

Table 1 Epidemiological and clinical analysis according to severity

From: Epidemiological and clinical assessment of a shared territorial malaria guideline in the 10 years of its implementation (Barcelona, North Metropolitan Area, Catalonia, Spain, 2007–2016)

 

Total (%)

Severe malaria (%)

Uncomplicated malaria (%)

p

Number of cases

190 (100)

34 (17.9%)

156 (82.1%)

Mean age (DE)

32 (13.8)

35.3 (11.1)

31.2 (14.3)

NS

Sex

 Men

121 (63.7)

27 (79.4)

94 (60.3)

0.04

 Women

69 (36.3)

7 (20.6)

62 (39.7)

 

Species

 P. falciparum

122 (64.2)

27 (79.4)

95 (60.9)

NS

 P. vivax

44(23.2)

4 (11.8)

40 (25.6)

 

 P. ovale

2 (1.1)

0 (0)

2 (1.3)

 

 P. malariae

3 (1.6)

0 (0)

3 (1.9)

 

 P. spp.

14 (7.4)

2 (5.9)

12 (7.7)

 

 Co-infectionsa

5 (2.6)

1 (2.9)

4 (2.6)

 

Positive Immunocromatography (N = 124)

109 (87.9)

27 (90)

82 (85.4)

NS

Travel destination

 Sub-Saharan Africa

142 (74.7)

33 (97.1)

109 (69.9)

0.02

 Indian sub-continent

46 (24.2)

1 (2.9)

45 (28.8)

0.003

 Amèrica

2 (1.1)

0 (0)

2 (1.3)

 

Length of trip ≤ 30 days (N = 147)

39 (26.5)

10 (29.4)

29 (18.5)

NS

Presence of risk factorsb

8 (4.2)

0 (0)

8 (5.1%)

NS

Immigrant

164 (86.3)

25 (73.5)

139 (89.1)

0.01

Travel reason

 Tourism

8 (4.2)

5 (14.7)

3 (1.9)

 

 VFRs

171 (90)

25 (73.5)

146 (93.6)

<0.001

 Business

11 (5.8)

4 (11.8)

7 (4.5)

 

Prior travel advice

26 (13.7)

5 (14.7)

21 (13.4)

NS

Chemoprophylaxis

19 (10)

4 (11.8)

15 (9.6)

NS

Care level

 Primary care

64 (33.7)

2 (5.9)

62 (39.7)

<0.001

 Emergency area

34 (17.9)

3 (8.8)

31 (19.9)

 

 Medicine ward

87 (45.8)

24 (70.6)

63 (40.4)

<0.001

 ICU

5 (2.6)

5 (14.7)

0 (0)

 

Treatment

 Quinine

71 (37.4)

29 (85.3)

42 (26.9)

<0.001

 Artemether

4 (2.1)

1 (2.9)

3 (1.9)

 

 Atovaquone/Prog.

62 (32.6)

2 (5.9)

60 (38.5)

<0.001

 Other

53 (27.9)

2 (5.9)

51 (32.7)

 

Sequelae at discharge

3 (1.6)

3 (8.8)

0 (0)

NS

Favourable clinical evolution (to 30 days)

190 (100)

34 (100)

156 (100)

Mortality

0 (0)

0 (0)

0 (0)

  1. a P. falciparum-P. malariae: 1, P. falciparum-P. ovale: 4
  2. bImmunodeficiency: 5, pregnancy: 2, age < 1: 1